Literature DB >> 3441501

Localization of mono-L-aspartyl chlorin e6 (NPe6) in mouse tissues.

K Aizawa, T Okunaka, T Ohtani, H Kawabe, Y Yasunaka, S O'Hata, N Ohtomo, K Nishimiya, C Konaka, H Kato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3441501     DOI： 10.1111/j.1751-1097.1987.tb04849.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN： 0031-8655            Impact factor:   3.421


× No keyword cloud information.
  10 in total

1.  Advantages of salvage photodynamic therapy using talaporfin sodium for local failure after chemoradiotherapy or radiotherapy for esophageal cancer.

Authors:  Tatsunori Minamide; Yusuke Yoda; Keisuke Hori; Kensuke Shinmura; Yasuhiro Oono; Hiroaki Ikematsu; Tomonori Yano
Journal:  Surg Endosc       Date:  2019-05-28       Impact factor: 4.584

2.  Tumor viability using real-time spectral images.

Authors:  Koji Asai; Yoshinobu Sumiyama; Manabu Watanabe; Katsuo Aizawa
Journal:  Surg Today       Date:  2006-12-25       Impact factor: 2.549

3.  In vitro behavior of Porfimer sodium and Talaporfin sodium with high intensity pulsed irradiation.

Authors:  Sayaka Ohmori; Tsunenori Arai
Journal:  Lasers Med Sci       Date:  2006-09-22       Impact factor: 3.161

4.  Tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC): application for photodynamic therapy and boron neutron capture therapy.

Authors:  Ryo Hiramatsu; Shinji Kawabata; Hiroki Tanaka; Yoshinori Sakurai; Minoru Suzuki; Koji Ono; Shin-ichi Miyatake; Toshihiko Kuroiwa; Erhong Hao; M Graça H Vicente
Journal:  J Pharm Sci       Date:  2014-12-26       Impact factor: 3.534

5.  Uptake and retention of the photosensitizer mono-L-asparthyl chlorine e6 in experimental malignant glioma.

Authors:  Hiroyuki Matsumura; Jiro Akimoto; Jo Haraoka; Katsuo Aizawa
Journal:  Lasers Med Sci       Date:  2007-08-17       Impact factor: 3.161

6.  Tissue damage in the canine normal esophagus by photoactivation with talaporfin sodium (laserphyrin): a preclinical study.

Authors:  Takahiro Horimatsu; Manabu Muto; Yusuke Yoda; Tomonori Yano; Yasumasa Ezoe; Shinichi Miyamoto; Tsutomu Chiba
Journal:  PLoS One       Date:  2012-06-13       Impact factor: 3.240

7.  Fluorescence characteristics and lifetime images of photosensitizers of talaporfin sodium and sodium pheophorbide a in normal and cancer cells.

Authors:  Kamlesh Awasthi; Kazuhito Yamamoto; Kazunari Furuya; Takakazu Nakabayashi; Liming Li; Nobuhiro Ohta
Journal:  Sensors (Basel)       Date:  2015-05-18       Impact factor: 3.576

8.  Therapeutic Options for Recurrent Glioblastoma-Efficacy of Talaporfin Sodium Mediated Photodynamic Therapy.

Authors:  Tatsuya Kobayashi; Masayuki Nitta; Kazuhide Shimizu; Taiichi Saito; Shunsuke Tsuzuki; Atsushi Fukui; Shunichi Koriyama; Atsushi Kuwano; Takashi Komori; Kenta Masui; Taketoshi Maehara; Takakazu Kawamata; Yoshihiro Muragaki
Journal:  Pharmaceutics       Date:  2022-02-02       Impact factor: 6.321

9.  Photodynamic Therapy by Glucose Transporter 1-Selective Light Inactivation.

Authors:  Kazuki Miura; Yijin Wen; Michihiko Tsushima; Hiroyuki Nakamura
Journal:  ACS Omega       Date:  2022-09-16

10.  Photodynamic therapy using a diode laser with mono-L-aspartyl chlorin e6 for implanted fibrosarcoma in mice.

Authors:  T Katsumi; K Aizawa; T Okunaka; Y Kuroiwa; Y Ii; K Saito; C Konaka; H Kato
Journal:  Jpn J Cancer Res       Date:  1994-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.